Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial.

MLA

Webb, Alastair J. S., et al. “Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial.” Circulation Research, vol. 135, no. 2, July 2024, pp. 320–31. EBSCOhost, https://doi.org/10.1161/CIRCRESAHA.124.324327.

APA

Webb, A. J. S., Birks, J. S., Feakins, K. A., Lawson, A., Dawson, J., Rothman, A. M. K., Werring, D. J., Llwyd, O., Stewart, C. R., & Thomas, J. (2024). Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation Research, 135(2), 320–331. https://doi.org/10.1161/CIRCRESAHA.124.324327

Chicago

Webb, Alastair J S, Jacqueline S Birks, Karolina A Feakins, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David J Werring, Osian Llwyd, Catriona R Stewart, and James Thomas. 2024. “Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial.” Circulation Research 135 (2): 320–31. doi:10.1161/CIRCRESAHA.124.324327.